Modelling prognostic factors in advanced pancreatic cancer
about
Expression of telomerase & its significance in the diagnosis of pancreatic cancerPredicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data.Survival prediction for pancreatic cancer patients receiving gemcitabine treatment.De Ritis ratio (AST/ALT) as an independent predictor of poor outcome in patients with acute ischemic stroke.Modeling prognostic factors in resectable pancreatic adenocarcinomas.Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes.Tumor size as measured at initial X-ray examination, not length of bile duct stricture, predicts survival in patients with unresectable pancreatic cancer.Digoxin associates with mortality in ESRD.Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial.Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.The clinical use of biomarkers as prognostic factors in Ewing sarcoma.Transaminase Activity Predicts Survival in Patients with Head and Neck CancerPrognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients.The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas.Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience.Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma.Influence of Preoperative Serum Aspartate Aminotransferase (AST) Level on the Prognosis of Patients with Non-Small Cell Lung Cancer.Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based ChemotherapyPrognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.A proposed model for prediction of survival based on a follow-up study in unresectable pancreatic cancer.Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survivalThe Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.Varying postresection lactate dehydrogenase with overall survival of early stage pancreatic cancer patients: A retrospective study.Prognostic factors related with survival in patients with pancreatic adenocarcinomaCurrent and future biomarkers for pancreatic adenocarcinoma.The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin.Prognostic significance of DNA cytometry for adjuvant therapy response in pancreatic cancer.Primary pancreatic lymphoma: what we need to know.Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study.ANO9/TMEM16J promotes tumourigenesis via EGFR and is a novel therapeutic target for pancreatic cancer.The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.The effect of AST/ALT (De Ritis) ratio on survival and its relation to tumor histopathological variables in patients with localized renal cell carcinoma.
P2860
Q27000718-94CAEDBE-DEAE-4848-BB01-12D049B6F9CCQ31052763-5B095C7A-F8C8-4F60-BAC7-E6458EB15A14Q33812871-67A7E7A8-6371-4F87-B2E7-97B65BD25296Q33817919-3DF6B3DC-201B-4C02-9AD8-2B47854AD687Q33831911-8CA5590B-DA26-48DF-9E1E-CF68BFA33F70Q34276961-537FAF4A-2379-45A2-B0C4-F8214AE1DA60Q34421240-31A745A2-27E4-421C-8462-C14FD236C6CEQ34455390-2B825504-B96B-4539-8CC3-A4739E54E9B1Q34484260-E87B076F-D0E4-439C-ABDF-8987BC958BA9Q35057350-BDD3F566-C6FC-4707-9DA6-8F8988CEF443Q35957979-A19C8F82-5278-4625-96B8-9123B93C7F84Q36161469-BB8C5E27-7DB7-4C8D-A4F9-3721A9687064Q36241168-C98B59D2-AFAE-4903-B3C1-1054D580A222Q36569129-E6CA4952-0EE6-4ED7-B2A1-89CD8D5FD62EQ37038460-AEF089F0-9A82-4670-8D0E-F77970FC23ECQ37168250-FA991D31-99CA-4928-897A-D68E2A4DCDECQ37286453-67CB3787-A7C6-44D4-8933-AEAC98F3FEC3Q37367435-BDD4071F-33C3-4A2E-8E40-7A24947B3DABQ37367504-953B156E-9780-48F0-BE56-09E192039AA3Q37448561-919A050D-1B86-48CF-A0A0-CF6F05A22A79Q37562530-F3C26556-9F1A-462C-932E-B2F136C50E23Q37710295-D88D4CAB-84EC-4F8C-945A-B2CB78336793Q37716372-C35412EA-6CFF-424E-9C0C-91ADD681A61BQ37727266-276D6B92-1815-4A33-B2BA-D2610F26EEFFQ38242807-A9E0932F-8671-4035-95E0-F568B9900110Q38670577-86A32E1A-3584-4468-BA08-C43EEC254BD4Q38698128-389235FF-0549-4502-A4BF-1FB1162AAC1CQ39735678-64C120A7-D487-4306-8006-D4907C90822DQ40502145-FA5D6C07-89ED-4761-BC76-74448E48A863Q41566970-2FCA0E54-95E2-4065-A162-C882D02638DBQ41598507-B291E09A-BE33-4330-925E-6EAE86B4456FQ42373339-95E8F67E-20FB-4EB0-86F7-DB18AEA7EBF5Q47661281-1B25B68B-20ED-4721-A011-B0E7A8BD8B4AQ48172966-0BF32F8C-143E-4956-BD4A-D149DC0892D4Q48234367-9AB9F573-E2E1-42D6-ABB3-6B26DF6BCB25Q50050970-73EF0FBD-B2EB-4ABA-9786-AC429995B856
P2860
Modelling prognostic factors in advanced pancreatic cancer
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Modelling prognostic factors in advanced pancreatic cancer
@en
type
label
Modelling prognostic factors in advanced pancreatic cancer
@en
prefLabel
Modelling prognostic factors in advanced pancreatic cancer
@en
P2093
P2860
P356
P1476
Modelling prognostic factors in advanced pancreatic cancer
@en
P2093
A B Hassan
D D Stocken
D G Altman
L J Billingham
N Freemantle
P J Johnson
S R Bramhall
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604568
P407
P577
2008-09-01T00:00:00Z
P5875
P6179
1021487325